Cited by 245Patient-Provider Communication in HealthcareCancer survivorship and careBreast Cancer Treatment Studies

The DOI matches its Crossref record, with a small difference in title or year; 44 of the 44 references it cites were found in a registry or an index.

Patient Centered Experiences in Breast Cancer: Predicting Long-Term Adherence to Tamoxifen Use

Kahn, Katherine L., Schneider, Eric C., Malin, Jennifer L., Adams, John L., Epstein, Arnold M.·2007·Medical Care

DOI 10.1097/01.mlr.0000257193.10760.7f

Open this paper in CoChat — free account

Abstract

BACKGROUND: Among breast cancer patients, tamoxifen use is associated with reduced risk of disease relapse and death, but it is often difficult for women to sustain therapy during the 5 years required to obtain maximum benefit. OBJECTIVES: We sought to examine the influence of patient-centered care activities on ongoing tamoxifen use 4 years after initiation, we examined key components of patient-centered care and rates of ongoing tamoxifen. METHODS: Using a prospective cohort study that included observational data from the National Initiative for Cancer Care Quality (NICCQ), we studied 881 patients with stage I-III breast cancer who were registered with an initial diagnosis in 1998 by an American College of Surgeons-approved hospital cancer registry in 1 of 5 metropolitan areas, who initiated tamoxifen treatment. A patient survey and medical record abstraction were used as measurements. RESULTS: Among women who initiated tamoxifen, 79% were still taking it 4 years later. Other than older age and the severity of side effects, other demographic, clinical and cancer characteristics, and treatments did not predict ongoing tamoxifen use. In contrast, after adjusting for these factors, the proportion of patients with ongoing tamoxifen use was lower for patients reporting less support than needed (82% vs. 69%, P = 0.0051), less than wanted role in decision-making (80% vs. 70%, P = 0.0486), decision-making about tamoxifen without doctor input (79% vs. 64%, P = 0.0182), and for patients who weren't told about side effects in advance (82% vs. 72%, P = 0.0016). CONCLUSIONS: Although age and the severity of side-effects remain important, patient-centered care was a primary mediator of patient adherence to ongoing cancer treatment with tamoxifen.

Integrity signals

Registry

Crossref · 10.1097/01.mlr.0000257193.10760.7f

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M. T., Cronin, W. M., Vogel, V. G., Robidoux, A., Dimitrov, N. S., Atkins, J. N., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,450
Tamoxifen for early breast cancer: an overview of the randomised trials
Abe, O., Bartholomeus, S., & Piccart, M. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,180
Crossing the Quality Chasm: A New Health System for the 21st Century
Bloom, B. S. (2002) · JAMA · doi:10.1001/jama.287.5.646-a · Cited by 3,733
The impact of patient-centered care on outcomes.
Stewart, M., Brown, J. B., DONNER, A. P., McWhinney, I. R., Oates, J., Weston, W. W., & Jordan, J. (2000) · PubMed · Cited by 2,508
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
Howell, A., Cuzick, J. M., Baum, M., Buzdar, A. U., Dowsett, M., Forbes, J., Hoctin-Boes, G., Houghton, J., Locker, G. Y., & Tobias, J. S. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17666-6 · Cited by 2,284
Assessing the Effects of Physician-Patient Interactions on the Outcomes of Chronic Disease
Kaplan, S. H., Greenfield, S., & Ware, J. E. (1989) · Medical Care · doi:10.1097/00005650-198903001-00010 · Cited by 2,043
Expanding Patient Involvement in Care
Greenfield, S., Kaplan, S. H., & Ware, J. E. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-4-520 · Cited by 1,459
Recall bias in epidemiologic studies
Coughlin, S. S. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90060-3 · Cited by 1,381
Effectiveness of Interventions to Improve Patient Compliance
ROTER, D. L., Hall, J. A., Merisca, R., Nordstrom, B. L., Cretin, D., & Svarstad, B. L. (1998) · Medical Care · doi:10.1097/00005650-199808000-00004 · Cited by 998

Show all 44 references

Sorted by citations

Items 101–200 of 245

Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions
Gil-Guillén, V. F., Balsa, A., Bernárdez, B., y Llorca, C. V., Contreras, E. M., de la Haba-Rodríguez, J., Castellano, J. M., & Martínez, J. C. G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912036 · Cited by 34
“Condition • Comorbidities [54,56,60,69,70,72,74–76,79,83,84,90,100–109] • Perception of severity of disease [56,61,69,76,79,103,110,111] • Perception of therapy’s risks and benefits [58]”
Background
Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer
Bhatta, S. S., Hou, N., Moton, Z., Polite, B. N., Fleming, G. F., Olopade, O. I., Huo, D., & Hong, S. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-356 · Cited by 30
“Measurements Prior studies using both self- report and pharmacy prescription refill records have used an 80% cut-off to define adherence since <80% adherence has been associated with increased mortality (Kahn et al. 2007; Molfenter et al. 2012; Stavropoulou 2011).”
BackgroundMethod
Factors predicting patient satisfaction in women with advanced breast cancer: a prospective study
Lam, W., Kwong, A., Suen, D. T. K., Tsang, J. W. H., Soong, I., Yau, T. K., Yeo, W., Suen, J. J. S., Ho, W. M., Wong, K. Y., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4085-3 · Cited by 29
“High patient satisfaction has been linked to better practice guideline adherence and lower inpatient mortality rates [2], as well as to greater patient acceptance and adherence to prescribed medical care [3, 4].”
Background
Perspectives of older adults with a chronic condition on functioning, social participation and health: a qualitative study
Coninck, L. D., Declercq, A., Bouckaert, L., Vermandere, M., Graff, M. J. L., & Aertgeerts, B. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02365-w · Cited by 28
Racial/Ethnic Differences in Use and Duration of Adjuvant Hormonal Therapy for Breast Cancer in the Women's Health Initiative
Livaudais, J. C., LaCroix, A. Z., Chlebowski, R. T., Li, C. I., Habel, L. A., Simon, M. S., Thompson, B., Erwin, D. O., Hubbell, F. A., & Coronado, G. D. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1225 · Cited by 29
“differences in long-term duration of use ( 4 years), although non-White racial/ethnic groups were combined in the multivariable analysis due to small numbers (19).”
Background
Oral Chemotherapy Medications: The Need for a Nurse's Touch
Winkeljohn, D. L. (2007) · Clinical journal of oncology nursing · doi:10.1188/07.cjon.793-796 · Cited by 28
Toxicity of extended adjuvant endocrine with aromatase inhibitors in patients with postmenopausal breast cancer: A Systemtic review and Meta-analysis
Zhao, F., Ren, D., Shen, G., Ahmad, R., Dong, L., Du, F., & Zhao, J. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103114 · Cited by 27
Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting
Verma, S., Madarnas, Y., Sehdev, S. R., Martin, G., & Bajcar, J. (2011) · Current Oncology · doi:10.3747/co.v18i0.899 · Cited by 27
Structural equation modeling of the proximal–distal continuum of adherence drivers
McHorney, C. A., Zhang, Stump, & Zhao (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s36535 · Cited by 27
“Both patient trust 167–171 and patient involvement 172–174 have been demonstrated in past research to be associated with improved medication adherence.”
Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy
Dorfman, C. S., Arthur, S. S., Kimmick, G. G., Westbrook, K. E., Marcom, P. K., Corbett, C. M., Edmond, S. N., & Shelby, R. A. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001337 · Cited by 25
“Nonadherence and early discontinuation of AET may be due, in part, to women’s experiences of treatment-related side effects.(13-17) Breast cancer survivors receiving AET report a”
Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: Nature and relevance for non-adherence
Wouters, H., van Geffen, E. C. G., Baas-Thijssen, M. C. M., Krol-Warmerdam, E. M., Stiggelbout, A. M., Belitser, S. V., Bouvy, M. L., & van Dijk, L. (2013) · The Breast · doi:10.1016/j.breast.2013.05.005 · Cited by 26
The Patient Experience of Ambulatory Cancer Treatment: A Descriptive Study
Bridge, E., Conn, L. G., Dhanju, S., Singh, S., & Moody, L. (2019) · Current Oncology · doi:10.3747/co.26.4191 · Cited by 26
THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer
Paladino, A. J., Anderson, J. N., Krukowski, R. A., Waters, T. M., Koçak, M., Graff, J. C., Blue, R., Jones, T. N., Buzaglo, J. S., Vidal, G. A., et al. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4588-x · Cited by 28
Young breast cancer patients' involvement in treatment decisions: the major role played by decision‐making about surgery
Seror, V., Cortaredona, S., Bouhnik, A., Meresse, M., Cluze, C., Viens, P., Rey, D., & Peretti‐Watel, P. (2013) · Psycho-Oncology · doi:10.1002/pon.3316 · Cited by 26
Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer
Iacorossi, L., Gambalunga, F., Fabi, A., Giannarelli, D., Marchetti, A., Piredda, M., & Marinis, M. G. D. (2016) · Cancer Nursing · doi:10.1097/ncc.0000000000000452 · Cited by 25
When attitudes and beliefs get in the way of shared decision‐making: A mediation analysis of participation preference
Büdenbender, B., Köther, A. K., Grüne, B., Michel, M. S., KRIEGMAIR, M. C., & Alpers, G. W. (2023) · Health Expectations · doi:10.1111/hex.13699 · Cited by 26
Precautions for Patients Taking Tamoxifen
Heery, M., Patrick Corbett, R., & Zelkowitz, R. (2018) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2018.9.1.6 · Cited by 23
Treating Elderly Patients with Hormone Receptor–Positive Advanced Breast Cancer
Riseberg, D. A. (2015) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s26067 · Cited by 22
Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study
Klepin, H. D., Geiger, A. M., Bandos, H., Costantino, J. P., Rapp, S. R., Sink, K. M., Lawrence, J. A., Atkinson, H. H., & Espeland, M. A. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0165 · Cited by 24
Reducing Racial Disparities in Breast Cancer Survivors' Ratings of Quality Cancer Care
Sheppard, V. B., Hurtado‐de‐Mendoza, A., Talley, C. H., Zhang, Y., Cabling, M. L., & Makambi, K. H. (2016) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000046 · Cited by 22
Rethinking agency and medical adherence technology: applying Actor Network Theory to the case study of Digital Pills
Hurtado‐de‐Mendoza, A., Cabling, M. L., & Sheppard, V. B. (2015) · Nursing Inquiry · doi:10.1111/nin.12101 · Cited by 21
Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer
Meneveau, M. O., Keim‐Malpass, J., Camacho, T. F., Anderson, R. T., & Showalter, S. L. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05908-8 · Cited by 21
Factors related to self-care drug treatment and medication adherence of elderly people in Japan
Ueno, H., Ishikawa, H., Kato, M., Okuhara, T., Okada, H., & Kiuchi, T. (2021) · Public Health in Practice · doi:10.1016/j.puhip.2021.100106 · Cited by 23
Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines
Hall, L., King, N. V., Graham, C. D., Green, S. M. C., Barber, A., Neal, R. D., Foy, R., Clark, J., Lloyd, K. E., & Smith, S. G. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-021-01114-7 · Cited by 22
Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93
Pagani, O., Gelber, S. I., Colleoni, M. A., Price, K. N., & Simoncini, E. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2757-x · Cited by 20
Adherence to Adjuvant Endocrine Therapy for Breast Cancer: Importance in Women with Low Income
Ursem, C. J., Bosworth, H. B., Shelby, R. A., Hwang, W., Anderson, R. T., & Kimmick, G. G. (2015) · Journal of Women s Health · doi:10.1089/jwh.2014.4982 · Cited by 21
Tamoxifen Acceptance and Adherence among Patients with Ductal Carcinoma In Situ (DCIS) Treated in a Multidisciplinary Setting
Karavites, L. C., Kane, A., Zaveri, S. R., Xu, Y., Helenowski, I., Hansen, N. M., Bethke, K. P., Rasmussen‐Torvik, L. J., & Khan, S. A. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0029 · Cited by 20
“Reports for adherence to tamoxifen by women with DCIS also varied widely (6, 7) and may relate to women's perceptions of less social support from health care providers (27); this may be compounded by a lack of consensus about therapy recommendations among different prescribers (28, 29).”
Background
Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women
Kuba, S., Maeda, S., Matsumoto, M., Yamanouchi, K., Yano, H., Morita, M., Sakimura, C., Hatachi, T., Tokai, Y., Takatsuki, M., et al. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.12.003 · Cited by 21
“Another questionnaire study reported that discontinuation and nonadherence to endocrine therapy were lower in patients reporting a lack of support and communication, and lack of information on side effects.(15,16) Our results supported these previous studies, in that patients more likely to consult with medical staff…”
Result
Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients
Mao, D., Hachem, H., Chang, H., Dima, D., Dower, J., Wismer, M., Erban, J. K., Freund, K. M., & Parsons, S. K. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05892-z · Cited by 20
Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients
Yusufov, M., Nathan, M., Wiley, A., Russell, J. A., Partridge, A. H., & Joffe, H. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05920-y · Cited by 21
L’adhésion thérapeutique aux traitements oraux : enjeux en oncologie - l’exemple du cancer du sein
Huiart, L., Bardou, V., & Giorgi, R. (2013) · Bulletin du Cancer · doi:10.1684/bdc.2013.1830 · Cited by 23
Associations of Self-rated Health and Socioeconomic Status with Information Seeking and Avoiding Behavior among Post-Treatment Cancer Patients
Jung, M. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.5.2231 · Cited by 20
“Because informed patients actively interact with their medical providers to achieve the desired health outcome and manage their symptoms for themselves (Kahn et al., 2007), they are a desirable patient group for today’s changing medical environment.”
Background
Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: Protocol for a pilot fractional factorial trial
Smith, S. G., Green, S. M. C., Ellison, R., Foy, R., Graham, C. D., Mason, E., French, D. P., Hall, L. H., Wilkes, H., McNaught, E., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069971 · Cited by 20
Practical applications of methods to incorporate patient preferences into medical decision models: a scoping review
Fusiak, J., Sarpari, K., Ma, I., Mansmann, U., & Hoffmann, V. S. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02945-5 · Cited by 19
“Studies have shown that this misalignment can lead to lower patient satisfaction [2], reduced treatment adherence [3], and poorer health outcomes [4].”
Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I–III breast cancer?
Cahir, C., Barron, T. I., Sharp, L., & Bennett, K. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0851-9 · Cited by 20
Predictors of Adherence and Treatment Delays among African American Women Recommended to Receive Breast Cancer Chemotherapy
Gallups, S., Connolly, M. C., Bender, C. M., & Rosenzweig, M. Q. (2018) · Women s Health Issues · doi:10.1016/j.whi.2018.08.001 · Cited by 19
Providers of follow-up care in a population-based sample of breast cancer survivors
Friese, C. R., Martinez, K. A., Abrahamse, P. H., Hamilton, A. S., Graff, J. J., Jagsi, R., Griggs, J. J., Hawley, S. T., & Katz, S. J. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2851-8 · Cited by 19
Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
Kittaneh, M., & Glück, S. (2011) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s6234 · Cited by 19
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)
Shelby, R. A., Dorfman, C. S., Bosworth, H. B., Keefe, F., Sutton, L., Owen, L., Corsino, L., Erkanli, A., Reed, S. D., Arthur, S. S., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.11.010 · Cited by 18
Adherence to Anti-estrogen Therapy in Seniors with Breast Cancer: How Well are we Doing?
Trabulsi, N. H., Riedel, K., Winslade, N. E., Grégoire, J., Meterissian, S. H., Abrahamowicz, M., Tamblyn, R. M., Mayo, N. E., & Meguerditchian, A. N. (2014) · The Breast Journal · doi:10.1111/tbj.12328 · Cited by 18
Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer
Montagna, E., Zagami, P., Masiero, M. A., Mazzocco, K., Pravettoni, G., & Munzone, E. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s285768 · Cited by 18
“As for endocrine treatments, Fink et al in a longitudinal study on 516 patients with ER-positive tumors reported that 17% of women stopped taking tamoxifen during the 2-year follow-up stage due to Table 3 Studies on Psycho-Social Processes Underlying Non-Adherence to Tamoxifen Authors Year Type of Study Patients (N) D…”
BackgroundInfluential
Adherence to adjuvant endocrine therapy in women with breast cancer
Danilak, M., & Chambers, C. R. (2012) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155212455939 · Cited by 18
The Patient-Centered Care and Receipt of Preventive Services Among Older Adults With Chronic Diseases: A Nationwide Cross-sectional Study
Liang, H., Zhu, J., Kong, X., Beydoun, M. A., Wenzel, J. A., & Shi, L. (2017) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/0046958017724003 · Cited by 18
Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial
Ream, M. E., Walsh, E. A., Jacobs, J. M., Taub, C. J., Lippman, M. E., Solle, N. S., Safren, S. A., & Antoni, M. H. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06361-x · Cited by 17
“Covariates were selected based on previous literature suggesting a role in medication-taking behaviors [5, 28, 29] and because of their theoretical implications for both intentional nonadherence (i.”
MethodResult
Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study
Sugita, K., Kawakami, K., Yokokawa, T., Sugisaki, T., Takiguchi, T., Aoyama, T., Suzuki, K., Suenaga, M., Yamaguchi, K., Inoue, A., et al. (2016) · Oncology · doi:10.1159/000448717 · Cited by 18
Investigating Associations Between Health-Related Quality of Life and Endocrine Therapy Underuse in Women With Early-Stage Breast Cancer
Pinheiro, L. C., Wheeler, S. B., Reeder-Hayes, K. E., Samuel, C. A., Olshan, A. F., & Reeve, B. B. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.018630 · Cited by 17
Social inequalities in supportive care needs and quality of patient-centered care of cancer patients in Mexico
Doubova, S. V., Martínez-Vega, I. P., Infante-Castañeda, C., Aranda-Flores, C. E., Knaul, F. M., & Pérez‐Cuevas, R. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05615-6 · Cited by 17
Exploratory Factor Analysis of a Patient-Centered Cancer Care Measure to Support Improved Assessment of Patients’ Experiences
Mitchell, K. R., Brassil, K. J., Fujimoto, K., Fellman, B. M., Shay, L. A., & Springer, A. E. (2019) · Value in Health · doi:10.1016/j.jval.2019.10.004 · Cited by 17
Risks of nonadherence to hormone therapy in Asian women with breast cancer
Hsieh, K., Chen, L., Cheung, K., & Yang, Y. (2015) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2015.04.002 · Cited by 16
Predictors of non-adherence to systemic oral therapy for advanced hepatocellular carcinoma
Mallick, R., Cai, J. X., & Wogen, J. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.842161 · Cited by 16
Adherence to hormone therapy in women with breast cancer: a quantitative study.
Iacorossi, L., Gambalunga, F., Fabi, A., Giannarelli, D., Facchinetti, G., Piredda, M., & Marinis, M. G. D. (2016) · PubMed · doi:10.7429/pi.2016.692113 · Cited by 17
The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation
Gomaa, S., López, A., Slamon, R., Smith, R. M., Telushi, E., Lapitan, E., Nightingale, G., Miller, S., & Wen, K. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08170-y · Cited by 15
Assessing patient adherence to a complementary medicine treatment regimen in an integrative supportive care setting
Ben‐Arye, E., Kruger, D., Samuels, N., Keinan‐Boker, L., Shalom, T., & Schiff, E. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-2016-z · Cited by 15
Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
Yang, S., Park, S. W., Bae, S. J., Ahn, S. G., Jeong, J., & Park, K. (2023) · Journal of Breast Cancer · doi:10.4048/jbc.2023.26.e22 · Cited by 16
Power asymmetry and embarrassment in shared decision-making: predicting participation preference and decisional conflict
Scherer, K. A., Büdenbender, B., Blum, A. K., Grüne, B., KRIEGMAIR, M. C., Michel, M. S., & Alpers, G. W. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02938-4 · Cited by 15
Women with breast cancer’s perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study
Gagné, M. E., Lauzier, S., Lemay, M., Loiselle, C. G., Provencher, L., Simard, C., & Guillaumie, L. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-021-06692-x · Cited by 14
Persistence with bisphosphonates in patients with metastatic breast cancer: a retrospective database analysis
Hadji, P., Ziller, V., Kyvernitakis, I., Schmidt, N., & Kostev, K. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1427-z · Cited by 13
Adherence to oral anticancer agents: Healthcare providers’ perceptions, beliefs and shared decision making in Belgium and the Netherlands
Verbrugghe, M., Timmers, L., Boons, C. C. L. M., van den Bemt, B. J. F., Hugtenburg, J. G., & Hecke, A. V. (2016) · Acta Oncologica · doi:10.3109/0284186x.2015.1119307 · Cited by 13
“more (73%) or less expanded role (59%) than wanted regarding the decision making process [8].”
BackgroundInfluential
Correspondence Between Objective and Self-reported Endocrine Therapy Adherence Among Women With Breast Cancer
Bright, E. E., & Stanton, A. L. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kay094 · Cited by 13
Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
Tetzlaff, E. D., & Davey, M. P. (2013) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2013.4.4.4 · Cited by 12
A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy
Pieters, H. C., Green, E., Khakshooy, S., Sleven, M., & Stanton, A. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210972 · Cited by 13
“In accordance with a previous study of women aged 21–80 years [26], our participants knew how much and what type of information they wanted.”
Result
Pretreatment Predictors of Short-Term Nonadherence to Oral Hormonal Therapy for Women With Breast Cancer
Wickersham, K. E., Sereika, S. M., & Bender, C. M. (2013) · Nursing Research · doi:10.1097/nnr.0b013e318298fd70 · Cited by 12
“Positive hormone receptor status has been associated with both ongoing tamoxifen use at 4 years (Kahn et al., 2007) and with stopping tamoxifen therapy by the second year (Fink et al., 2004).”
BackgroundInfluential
Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer
Xuan, Q., Gao, K., Song, Y., Zhao, S., Dong, L., Zhang, Z., Zhang, Q., & Wang, J. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.07.006 · Cited by 12
Persistence with tamoxifen and aromatase inhibitors in Germany: a retrospective cohort study with 284,383 patients
Gremke, N., Griewing, S., Chaudhari, S., Upadhyaya, S., Nikolov, I., Kostev, K., & Kalder, M. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04376-5 · Cited by 12
Characteristics and Determinants of Patients Discontinuation of Breast Cancer Follow-Up Care at the Radiation Oncology Department, University College Hospital, Ibadan, Nigeria
Dairo, M. D., Adamu, S., Onimode, Y., Ntekim, A., & Ayeni, O. (2018) · International Journal of Breast Cancer · doi:10.1155/2018/1597964 · Cited by 11
Providers’ perspectives on adherence to hormonal therapy in breast cancer survivors. Is there a role for the digital health feedback system?
Hurtado‐de‐Mendoza, A., Cabling, M. L., Dilawari, A. A., Turner, J. W., Fernández, N. C., Henderson, A., Zhu, Q., Gómez‐Trillos, S., & Sheppard, V. B. (2018) · Health and Technology · doi:10.1007/s12553-018-0267-x · Cited by 12
Financial incentives for quality in breast cancer care.
Tisnado, D. M., Rose-Ash, D. E., Malin, J. L., Adams, J., Ganz, P. A., & Kahn, K. L. (2008) · PubMed · Cited by 11
Self-citation
Moving Research From Bench to Bedside to Community: There Is Still More to Do
Kahn, K. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1870 · Cited by 11
“Symptoms were the most important predictor of discontinuing long-term use.(38) However, even after adjustment for symptom onset and intensity, patient-centered care was the most important predictor of ongoing adjunct tamoxifen use in the setting of new onset breast cancer.”
BackgroundSelf-citation
Patient and health care professional co-development of an Acceptance and Commitment Therapy intervention to support hormone therapy decision-making and well-being in women with breast cancer
Hall, L. H., Clark, J., Smith, S. G., Graham, C. D., & for the ACTION investigators (2022) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2021.1955318 · Cited by 10
Improving medication adherence to endocrine therapy in breast cancer patients: a mixed-methods systematic review of effective communication strategies for healthcare providers
Smits, M. A. A., Mammatas, L. H., Schoonhoven, L., & Vervoort, S. C. J. M. (2025) · The Breast · doi:10.1016/j.breast.2025.104510 · Cited by 11
“Still, despite these limitations, we have carefully reviewed and combined the evidence to ensure our findings are based on the most reliable and consistent results.”
Evaluating the Relationship between Compassion, Perceived Supervisor Support, and Burnout among ABA Staff
Austin, A., & Fiske, K. (2023) · Behavior Analysis in Practice · doi:10.1007/s40617-023-00813-0 · Cited by 10
Discontinuation of hormone therapy for elderly breast cancer patients after hypofractionated whole-breast radiotherapy
Dispinzieri, M., Rocca, E. L., Meneghini, E., Fiorentino, A., Lozza, L., Cosimo, S. D., Gennaro, M., Cosentino, V., Sant, M., Pignoli, E., et al. (2018) · Medical Oncology · doi:10.1007/s12032-018-1165-9 · Cited by 10
Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosis
van Eijndhoven, E. A., Brauer, M., Kee, R., MacEwan, J. P., Mucha, L., Wong, S. L., Durand, A., & Shafrin, J. T. (2020) · Journal of Medical Economics · doi:10.1080/13696998.2019.1711100 · Cited by 10
Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
Villarreal-Garza, C. M., Mesa-Chávez, F., Ferrigno, A. S., la Garza‐Ramos, C. D., Fonseca, A., Villanueva-Tamez, K., Campos-Salgado, J. Y., Cruz‐Ramos, M., Rodriguez-Gomez, D. O., Ruiz-Cruz, S., et al. (2021) · The Breast · doi:10.1016/j.breast.2021.05.013 · Cited by 10
Non-adherence to the Use of Tamoxifen in the First year by the Breast Cancer Patients in an African Population
Oguntola, A., Adeoti, M. L., & Akanbi, O. O. (2011) · TSpace (University of Toronto) · Cited by 10
Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
Lambert, L. K., Balneaves, L. G., Howard, A. F., Chia, S., & Gotay, C. C. (2021) · Current Oncology · doi:10.3390/curroncol28020139 · Cited by 8
“of the patient-physician relationship [23], frequent, patient-centered communication [24,25], preparedness for the possibility of side effects and physician involvement in decisionmaking [23] were significantly correlated with greater AET adherence.”
Background
A competing risk analysis of hormone therapy interruption in Asian women with breast cancer
Hsieh, K., Chen, L., Cheung, K., & Yang, Y. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3733 · Cited by 9
The need for advanced breast cancer treatment guidelines: Results of an internet-based survey
Wardley, A. M. (2007) · The Breast · doi:10.1016/j.breast.2007.10.014 · Cited by 9
Quality of Care, Including Survivorship Care Plans
Hershman, D. L., & Ganz, P. A. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16366-6_17 · Cited by 9
Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions
Rassy, E., Bardet, A., Bougacha, O., Gantzer, L., Lekens, B., Delaloge, S., André, F., Michiels, S., & Pistilli, B. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.44849 · Cited by 8
Exploring the views and experiences of HIV positive patients treated for cancer: a systematic review of the literature
Hainsworth, E. G., Shahmanesh, M., & Stevenson, F. A. (2017) · AIDS Care · doi:10.1080/09540121.2017.1381332 · Cited by 8
What Is Quality Health Care for Cancer Survivors?
Malin, J. L., Sayers, E., & Jefford, M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1348-7_2 · Cited by 8
“Factors predicting non-adherence include older age and greater comorbidity but also having side effects from the medication [49], not being informed about side effects in advance of starting the medication, and having less support than needed [50], suggesting that adherence may improve with greater attention to the qu…”
Self-citation
Cyclin-Dependent Kinase 4/6 Inhibitors in the Treatment of Breast Cancer: More Breakthroughs and an Embarrassment of Riches
Griggs, J. J., & Wolff, A. C. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.9375 · Cited by 8
Health information acquisition and lifestyle choices among cancer survivors in China: Examining the roles of patient-centered communication, patient trust, and system trust
Ye, J. F., Zou, W., Huang, L., Lai, Y. K., Zhang, L., & Zhao, X. (2025) · Journal of Health Psychology · doi:10.1177/13591053251321782 · Cited by 7
“In particular, breast cancer survivors experiencing higher levels of PCC showed continued adherence to recommended drug treatments 4 years post-diagnosis and engaged more in healthy lifestyle behaviors (Kahn et al., 2007).”
Influencing Factors of Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients: A Meta‐Analysis
Wang, X., Jia, R., Xiang, G., Zhang, D., Wang, Y., & Xu, H. (2025) · Health Science Reports · doi:10.1002/hsr2.70934 · Cited by 8
“…95% CI: 1.37 – 2.15, I 2 = 89%, high statistical heterogeneity) [30, 34, 36, 44, 47, 49, 50, 52, 62, 64] and age ＞ 65 years (OR = 1.53, 95% CI: 1.35 – 1.74, I 2 = 80%, high statistical heterogeneity) [30, 33 – 38, 49, 50, 52, 57, 59, 63 – 65] were correlated with non ‐ adherence to AET treatment.”
Influential
Navigating Intercultural Medical Encounters: An Examination of Patient-Centered Communication Practices with Italian and Foreign Cancer Patients Living in Italy
Marino, F., Alby, F., Zucchermaglio, C., Scalisi, T. G., & Lauriola, M. (2023) · Cancers · doi:10.3390/cancers15113008 · Cited by 9
Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors
Uslu, Y., Kocatepe, V., Sezgin, D. S., & Uras, C. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07742-2 · Cited by 11
Identifying Social Characteristics of Health-Related Information Seeker: A Gender-Specific Approach for Cancer Survivors
Jung, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.5.1865 · Cited by 7
“Because informed survivors actively interact with their medical providers, they may be particularly able to accrue benefits in this shared system compared to survivors who are less informed (Charles et al., 2003; Kahn et al., 2007).”
Background
Adjuvant Endocrine Therapy in Breast Cancer: A Novel e-Health Approach in Optimizing Treatment for Seniors (OPTIMUM): A Two-Group Controlled Comparison Pilot Study
Meguerditchian, A. N., Tamblyn, R. M., Meterissian, S. H., Law, S., Prchal, J. F., Winslade, N. E., & Stern, D. (2016) · JMIR Research Protocols · doi:10.2196/resprot.6519 · Cited by 7
“Limited studies show that adherence to AET is a particular challenge in older women [39].”
Oncologists’ perspectives on adherence/non-adherence to adjuvant endocrine therapy and management strategies in women with breast cancer
Eraso, Y. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s211939 · Cited by 7
“In addition, patient-centered communication and higher patient’s self-efficacy have been shown as positive predictors of persistence with AET.(20,21) Furthermore, a recent systematic review found that persistence with AET was related to seeing a specialist (oncologist or mastologist) rather than a GP,(9,22) suggesting…”
Background
Developing and validating a theoretical measure of modifiable influences on hormonal therapy medication taking behaviour in women with breast cancer
Cahir, C., Dombrowski, S. U., Kennedy, M. J., Sharp, L., & Bennett, K. (2017) · Psychology and Health · doi:10.1080/08870446.2017.1296151 · Cited by 8
When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review
Wreyford, L., Gururajan, R., & Zhou, X. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282180 · Cited by 8
Patient Satisfaction in Rural Versus Non‐Rural US Hospitals
Vu, S., Reese, L., Patel, N., & Hung, M. (2024) · Public Health Challenges · doi:10.1002/puh2.219 · Cited by 6
Understanding immunotherapy terminology: An analysis of provider‐patient conversations
Blee, S. M., Rosenberg, B., Switchenko, J. M., Hianik, R. S., Thomson, M. C., Dixon, M. D., Bilen, M. A., & Pentz, R. D. (2021) · ImmunoMedicine · doi:10.1002/imed.1028 · Cited by 6
“The study obtained data from three sources: (1) provider-patient conversations about PD-1 or PDL1 checkpoint inhibitors; (2) post-conversation patient interviews; and (3) provider interviews.”
Method
Patients' Medication-Related Experience of Care Is Associated with Adherence to Cardiometabolic Disease Therapy in Real-World Clinical Practice
Romanelli, R. J., Huang, Q., LaMori, J. C., Doshi, D., & Chung, S. (2018) · Population Health Management · doi:10.1089/pop.2017.0163 · Cited by 6
Top Priorities for Health Service Improvements Among Australian Oncology Patients
Hall, A. E., Bryant, J., Sanson‐Fisher, R., Grady, A., Proietto, A. M., & Doran, C. M. (2021) · Patient Related Outcome Measures · doi:10.2147/prom.s291794 · Cited by 6
Adherence Rates and Correlates in Long-term Hormonal Therapy
Dunn, J., & Gotay, C. C. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-416673-8.00003-4 · Cited by 7
Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer?
Lee, J. T., Bridges, J. F. P., & Shockney, L. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.1.73 · Cited by 6
Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective study
Xing, P., Dong, H., Liu, Q., Yao, F., Xu, Y., Chen, B., Zheng, X., Wu, Y., Jin, F., & Li, J. (2017) · Oncotarget · doi:10.18632/oncotarget.18454 · Cited by 6
“A growing number of studies have pointed out that the side effects of tamoxifen are the main cause of the low adherence [47, 49, 50].”
Background
comunicación como elemento fundamental en la literatura especializada en experiencia de paciente (1989-2013)
Marca-Francés, G., Compte-Pujol, M., Menéndez-Signorini, J., & Frigola-Reig, J. (2021) · Revista de Comunicación y Salud · doi:10.35669/rcys.2021.11.e269 · Cited by 5

Authors: Kahn, K. L., Schneider, E. C., Malin, J. L., Adams, J. L., & Epstein, A. M.
Affiliations: RAND Corporation (US)
Brigham and Women's Hospital (US)
Amgen (United States) (US)
Corresponding author: Kahn, Katherine L.
Adams, John L.
ORCID: Schneider, Eric C.
Adams, John L.
Epstein, Arnold M.
Venue: Medical Care
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2007-05
Volume: 45
Issue: 5
Pages: 431-439
ISSN: 0025-7079 (ISSN-L)
DOI: 10.1097/01.mlr.0000257193.10760.7f
OpenAlex: W1979710912
Cited by: 245
References: 44
Citations by year: 2026: 3 · 2025: 11 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 20 · 2020: 13 · 2019: 10 · 2018: 17 · 2017: 18 · 2016: 16 · 2015: 17 · 2014: 16 · 2013: 29 · 2012: 14
FWCI: 12.51
Type: journal article
Language: en
Open access: closed
Locations: Medical Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
Health Sciences › Medicine › Oncology › Cancer survivorship and care
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: breast cancer, tamoxifen, patient-centered care, medication adherence, patient support, shared decision-making, treatment side effects
MeSH terms: Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Medical Audit, Middle Aged, Neoplasm Staging, Patient Compliance, Patient Participation, Prospective Studies, Tamoxifen, Time Factors, United States, Cohort Studies, Patient-Centered Care, Health Care Surveys

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Patient Centered Experiences in Breast Cancer: Predicting Long-Term Adherence to Tamoxifen Use

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks